[Pediatric management of early-onset neonatal sepsis: guidelines adherence in Lille's perinatal care network].

Neonatal early-onset infection has been recognized as a significant cause of perinatal mortality and morbidity, in spite of recent improvement in perinatal care. In France, Anaes guidelines were published in 2002.
To evaluate paediatricians' knowledge about these official guidelines in Lille's perinatal network.
Every network's paediatrician, working in a hospital maternity or in a neonatology unit received a questionnaire, to evaluate his knowledge about early onset sepsis diagnosis, indication and type of per partum antibiotherapy, and immediate neonatal care, according to perinatal factors.
Response rate was 55%. Thirty-five per cent of paediatricians underestimated gastric sample's diagnostic role and 41% prescribed a triple antibiotherapy. Duration of antibiotic treatment was too long in 56% of cases. Biologic tests were prescribed in excess in 71% of cases when a streptoccocal B mother's colonization was present. Per partum antibiotherapy was appropriated in only 29% of responses.
This study underlines imperfect official guidelines' knowledge, leading to ecological, bacterial, and economical consequences.
AuthorsM Alexandre-Treilles, M Chenaud, N Kacet, A Ego, P Truffert,
JournalArchives de pédiatrie : organe officiel de la Sociéte française de pédiatrie (Arch Pediatr) Vol. 13 Issue 4 Pg. 341-5 (Apr 2006) ISSN: 0929-693X [Print] France
Vernacular TitleSuivi des recommandations de prise en charge pédiatrique de l'infection maternofoetale: enquête au sein du réseau de soins périnatals de la métropole lilloise.
PMID16488584 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Clinical Competence
  • France
  • Guideline Adherence
  • Humans
  • Infant, Newborn
  • Middle Aged
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Sepsis (diagnosis, drug therapy)
  • Surveys and Questionnaires

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: